At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 119 enrolled
Drug / intervention
levodopa/carbidopa +3 moredrug
Likely dose
Ropinirole 2 mg/dfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cognitive-enhancing DA Medications for Cocaine Dependence
The University of Texas Health Science Center, Houston·interventional·Posted Jul 13, 2011·Updated Mar 29, 2018
In Brief
A Phase 2 clinical trial evaluating levodopa/carbidopa, Ropinirole 2 mg/d, and 2 other interventions for Cocaine Dependence. Completed, enrolled 119 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate treatments designed to improve cocaine treatment success by combining medications that target cocaine-related cognitive impairments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedJul 2011
Primary CompletionFeb 2017
TodayJul 2026
First PostedJul 13, 2011
Enrollment StartJun 1, 2011
Primary CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 15.0 years ago
Interventions
levodopa/carbidopadrug
800/200 mg/d
Ropinirole 2 mg/ddrug
2 mg/d
Placebodrug
sugar pill
Ropinirole 4 mg/ddrug
4 mg/d